Alp Buğra Başat
MD, PhD - Founder and Executive Director of Orpha Labs

Advances of OrphaLabs for Glycosylation Disorders

Host: Paula Videira

Short Bio

Dr. Alp Buğra Başat received his Medical Doctor degree with honors in 2013 from Hacettepe University School of Medicine in Ankara, Turkey.
Dr Başat has worked as a research intern, research scholar and post-doc research fellow in several high level institutions such as the Hacettepe School of Medicine (2007 – 2009), University of Oxford (2008), Harvard Medical School (2009), Beth Israel Deaconess Medical Center-Harvard Medical School (2010), Joslin Diabetes Center – Harvard Medical School (2011), University of California San Diego – La Jolla Institute (2013 – 2015).
During his research work, Dr Başat has been the author of several research publications and posters.
Moreover, Dr Başat has worked as a healthcare associate at Rhea Capital Partners (April 2014 – October 2014) and as an R&D consultant for Attenua, Inc. (July 2017 – September 2017). Since January 2018, Dr Başat is working as a consultant for Waimangu Ventures.
In 2014, Dr Başat founded Orpha Labs; a company committed to discovering and developing treatments for ultra-rare diseases, such as glycosylation disorders, and is currently working as the executive director.